NSE · Basic Materials · Specialty Chemicals
EPS came in at 5.48 against a street estimate of 5.35 — a beat of 2.4%.
with an average price target of ₹958.36.
CONFIDENT Clean Science delivered record ₹264cr consolidated revenue (Q1 FY27), with HALS emerging as 22% of sales. Two major partnerships—Geneus Chem (advanced HALS, ₹300–350cr potential over 4 years) and ChemLin (5-year supply deal, 20–30% volume growth)—signal expansion. Supply disruptions eased; margin pressure persists from raw material volatility. Q1 FY27 Domestic dominates core business; export penetration growing, especially in HALS where 50% now export vs. 100% domestic in prior year. Analysts probed sustainability of 43% margins (management cited grade mix & efficiency, not cheap RM); Geneus deal structure (co-branded, geographically split, ₹25cr CapEx); and OR-HALS differentiation (niche agri segment, non-cannibalistic, BASF-dominated today). Management emphasized partnerships are strategic, not financial engineering. 2026-08-01…
Full summary in the app.
Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for Clean Science and Technology Limited — free to start.
Google PlayApp StoreData updated 2026-08-05.